TransMedics Group jumps on full-year revenue forecast raise

TransMedics

06/11/2023 21:55

** Shares of medical technology company TransMedics Group
 TMDX.O  surge ~33.4% to $53.61 after the bell
    ** TMDX raises FY23 revenue forecast to a range of $222 mln
to $230 mln vs its prior outlook of $180 mln to $190 mln
    ** Company's Q3 revenue climbs to $66.4 mln compared with
$25.7 mln a year earlier
    ** Net loss in Q3 widened to $25.4 mln from $7.4 mln a year
earlier due to one-time acquisition-related costs
    ** As of last close, stock down ~34.9% YTD 

 (Reporting by Manya Saini in Bengaluru)
 ((Manya.Saini@thomsonreuters.com))